Bellerophon Therapeutics, Inc. Annual Earnings Per Share, Basic in USD/shares from 2016 to 2022

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Bellerophon Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2016 to 2022.
  • Bellerophon Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2023 was -0.16 USD/shares, a 69.8% increase year-over-year.
  • Bellerophon Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2023 was -0.84 USD/shares, a 57.8% increase year-over-year.
  • Bellerophon Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -2.08 USD/shares, a 11.2% decline from 2021.
  • Bellerophon Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -1.87 USD/shares, a 41% increase from 2020.
  • Bellerophon Therapeutics, Inc. annual Earnings Per Share, Basic for 2020 was -3.17 USD/shares, a 7.46% decline from 2019.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$2 $0 -11.2% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-31
2021 -$2 +$1.30 +41% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$3 $0 -7.46% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-31
2019 -$3 -$4 -504% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-31
2018 $0.73 +$21.80 Jan 1, 2018 Dec 31, 2018 10-K 2021-03-11
2017 -$21 -$20 -1236% Jan 1, 2017 Dec 31, 2017 10-K 2020-04-06
2016 -$2 Jan 1, 2016 Dec 31, 2016 10-K 2019-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.